Clinical trial
Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus…
NCT00229125 · National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH · Completed
Key facts
| NCT number | NCT00229125 |
|---|---|
| Title | Comparing the Treatment of Alcohol Withdrawal Syndrome Using Gabapentin Versus Lorazepam |
| Official title | Gabapentin Vs. Lorazepam in Alcohol Withdrawal |
| Lead sponsor | National Institute on Alcohol Abuse and Alcoholism (NIAAA), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcohol Withdrawal Syndrome(AWS) |
| Intervention type | Drug |
| Interventions | Gabapentin, Lorazepam |
| Enrollment | 160 |
| Start date | Jul 1, 2001 |
| Completion | Sep 1, 2005 |
| First posted | Sep 29, 2005 |
| Last update posted | Sep 29, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: